Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors

Transfusion

Volumn 52, Issue 3, 2012, Pages 537-541

  Olnes, Matthew J ^a,b,c   Poon, Andrea ^a,b,c   Miranda, Susan J ^a,b,c   Pfannes, Loretta ^a,b,c   Tucker, Zachary ^a,b,c   Loeliger, Kelsey ^a,b,c   Padilla Nash, Hesed ^a,b,c   Yau, Yu Ying ^a,b,c   Ried, Thomas ^a,b,c   Leitman, Susan F ^a,b,c   Young, Neal S ^a,b,c   Sloand, Elaine M ^a,b,c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b Clinical Center   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEUPLOIDY; ARTICLE; CELL CULTURE; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CONTROLLED STUDY; DONOR; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MONOSOMY 7; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SPECTRAL KARYOTYPING; TRISOMY 8;

ANEUPLOIDY; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; DEXAMETHASONE; GENOMIC INSTABILITY; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; TISSUE DONORS;

EID: 84856287199     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03313.x     Document Type: Article

References (20)

1. Haase D, Germing U, Schanz J, Pfeilstöcker M, Nösslinger T, Hildebrandt B, Kundgen A, Lübbert M, Kunzmann R, Giagounidis AA, Aul C, Trümper L, Krieger O, Stauder R, Müller TH, Wimazal F, Valent P, Fonatsch C, Steidl C,. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007; 110: 4385-95. (Pubitemid 351377805)
2. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS,. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 2002; 99: 3129-35. (Pubitemid 34525289)
3. Socie G, Mary JY, Schrezenmeier H, Marsh J, Bacigalupo A, Locasciulli A, Fuehrer M, Bekassy A, Tichelli A, Passweg J,. Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT). Blood 2007; 109: 2794-6. (Pubitemid 46482073)
4. Kojima S, Tsuchida M, Matsuyama T,. Myelodysplasia and leukemia after treatment of aplastic anemia with G-CSF. N Engl J Med 1992; 326: 1294-5.
5. Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N, Bordigoni P, Babin-Boilletot A, Bensaid P, Manel AM, Vilmer E, Thuret I, Blanche S, Gluckman E, Fischer A, Mechinaud F, Joly B, Lamy T, Hermine O, Cassinat B, Chomienne C, et al,.; French Severe Chronic Neutropenia Study Group. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005; 90: 45-53. (Pubitemid 40193753)
6. Kaplinsky C, Trakhtenbrot L, Hardan I, Reichart M, Daniely M, Toren A, Amariglio N, Rechavi G, Izraeli S,. Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplant 2003; 32: 31-4. (Pubitemid 36850277)
7. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L,. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004; 32: 122-30. (Pubitemid 38064408)
8. Marmier-Savet C, Larosa F, Legrand F, Witz B, Michallet M, Ranta D, Louvat P, Puyraveau M, Raus N, Tavernier M, Mathieu-Nafissi S, Hequet O, Pallandre JR, Vitte F, Collonge-Rame MA, Pouthier F, Bresson JL, Deconinck E, Tiberghien P, Robinet E,. G-CSF-induced aneuploidy does not affect CD34+ cells and does not require cell division. Blood 2010; 115: 910-1.
9. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L,. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 2003; 21: 1431-9. (Pubitemid 46594092)
10. Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR,. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 2007; 99: 196-205.
11. Pamphilon D, Nacheva E, Navarrete C, Madrigal A, Goldman J,. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors. Transfusion 2008; 48: 1495-501.
12. Gurion R, Gafter-Gvili A, Paul M, Vidal L, Ben-Bassat I, Yeshurun M, Shpilberg O, Raanani P,. Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis. Haematologica 2009; 94: 712-9.
13. Locasciulli A, Arcese W, Locatelli F, Di BE, Bacigalupo A,. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet 2001; 357: 43-4. (Pubitemid 32056504)
14. Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC,. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 2010; 150: 196-9.
15. Sloand EM, Yong AS, Ramkissoon S, Solomou E, Bruno TC, Kim S, Fuhrer M, Kajigaya S, Barrett AJ, Young NS,. Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci U S A 2006; 103: 14483-8. (Pubitemid 44484776)
16. Padilla-Nash HM, Barenboim-Stapleton L, Difilippantonio MJ, Ried T,. Spectral karyotyping analysis of human and mouse chromosomes. Nat Protoc 2006; 1: 3129-42.
17. de Haas M, Kerst JM, van der Schoot CE, Calafat J, Hack CE, Nuijens JH, Roos D, van Oers RH, von dem Borne AE,. Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils. Blood 1994; 84: 3885-94. (Pubitemid 24362489)
18. Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL,. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood 2009; 113: 3604-11.
19. Holig K, Kramer M, Kroschinsky F, Bornhäuser M, Mengling T, Schmidt AH, Rutt C, Ehninger G,. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood 2009; 114: 3757-63.
20. Quillen K, Byrne P, Yau YY, Leitman SF,. Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone. Transfusion 2009; 49: 513-8.